Skip to main content

Commentary regarding decision in Bilski from a biotech perspective

Buy Article:

$43.00 plus tax (Refund Policy)

Document Type: Research Article

DOI: http://dx.doi.org/10.1057/jcb.2010.19

Affiliations: Frommer Lawrence & Haug LLP, 745 Fifth Avenue, New York 10151, USA

Publication date: October 1, 2010

pal/jcb/2010/00000016/00000004/art00010
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more